REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 36 filers reported holding REGULUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,000 | +160.0% | 19,423 | +163.8% | 0.00% | – |
| Q1 2018 | $5,000 | – | 7,363 | – | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2017 | $68,000 | +3300.0% | 41,799 | +5124.9% | 0.01% | – |
| Q4 2016 | $2,000 | -77.8% | 800 | -72.1% | 0.00% | -100.0% |
| Q3 2016 | $9,000 | +28.6% | 2,866 | +282.6% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | -68.2% | 749 | -77.4% | 0.00% | -50.0% |
| Q3 2015 | $22,000 | -29.0% | 3,319 | +16.3% | 0.00% | -33.3% |
| Q2 2015 | $31,000 | -84.7% | 2,854 | -76.0% | 0.00% | -88.0% |
| Q1 2015 | $202,000 | +1162.5% | 11,911 | +409.0% | 0.02% | +1150.0% |
| Q3 2014 | $16,000 | -70.9% | 2,340 | -61.8% | 0.00% | -71.4% |
| Q1 2014 | $55,000 | +1733.3% | 6,126 | +1630.5% | 0.01% | +600.0% |
| Q4 2013 | $3,000 | -87.5% | 354 | -85.9% | 0.00% | -66.7% |
| Q3 2013 | $24,000 | – | 2,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |